| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |